Aislamiento de Candida spp. en ascitis de pacientes con cirrosis hepática / Isolation of Candida spp. from ascites in cirrhotic patients

El aislamiento de Candida spp. en el líquido ascítico (LA) de pacientes cirróticos es una situación infrecuente en la práctica clínica. Los factores que principalmente se han relacionado con una mayor predisposición a la peritonitis fúngica primaria (PFP) son la exposición a antibióticos de amplio espectro junto con la inmunosupresión, que es una situación característica de estos pacientes. Aportamos 7 episodios de aislamiento de Candida spp. en ascitis de pacientes cirróticos detectados en nuestro centro en los últimos 15 años

The isolation of Candida spp. in ascites of cirrhotic patients is an uncommon situation in clinical practice. Factors that have been associated with increased susceptibility to primary fungal peritonitis are exposure to broad-spectrum antibiotics and immunosuppression, a typical situation of these patients. We report seven episodes of Candida spp. isolation in ascites of cirrhotic patients detected in our hospital during the past 15 years

[Isolation of Candida spp. from ascites in cirrhotic patients]. / Aislamiento de Candida spp. en ascitis de pacientes con cirrosis hepática.

The isolation of Candida spp. in ascites of cirrhotic patients is an uncommon situation in clinical practice. Factors that have been associated with increased susceptibility to primary fungal peritonitis are exposure to broad-spectrum antibiotics and immunosuppression, a typical situation of these patients. We report seven episodes of Candida spp. isolation in ascites of cirrhotic patients detected in our hospital during the past 15years.

Cost-effectiveness of a Barcelona home care program for individuals with multimorbidity.

To improve the efficiency and effectiveness of care and optimize healthcare resources, a home healthcare program was created for individuals with multiple chronic conditions. Demographic and clinical characteristics of the 261 individuals (mean age 84) included in the program from its inception in 2011 through 2013 (mean stay in the program 203±192 days) were prospectively analyzed. The number of hospital admissions, length of stay, and costs for individuals admitted to the program were compared for two time periods: the 6 months before admission to the program and their stay in the program. After admission to the program, the number of hospital admissions and the hospital length of stay per person per month decreased from 0.36±0.21 to 0.19±0.52 (P<.001) and from 3.5 to 1 day (P<.001), respectively. Surveys of randomly selected patients and caregivers showed high satisfaction with the program. Costs per person per day decreased from €54.65 (US$73.12) to €17.91 (US$23.96), a reduction of 67.1%. Fewer admissions and shorter hospital stays enabled the hospital to eliminate one acute bed for every 50 individuals admitted to the program. In conclusion, home care for individuals with chronic illness with multimorbidity reduced the number of hospital admissions and length of stay, resulting in good patient satisfaction and lower costs.